Anticancer activity of newly synthesized azaphenothiazines from NCI's anticancer screening bank

Pharmacological Reports

Volumn 62, Issue 2, 2010, Pages 319-332

  Pluta, Krystian ^a   Jeleń, Małgorzata ^a   Morak Młodawska, Beata ^a   Zimecki, Michał ^b   Artym, Jolanta ^b   Kocieba, Maja ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Anticancer activity; Azaphenothiazines; Dipyridothiazines; Diquinothiazines

Indexed keywords

10H DIPYRIDOTHIAZINE; 5,6 ETHYLENEDIQUINOTHIAZINIUM CHLORIDE; 6 CHLOROETHYLUREIDOETHYLDIQUINOTHIAZINE; 6 DIETHYLAMINOETHYLDIQUINOTHIAZINE; 6 DIMETHYLAMINOPROPYLDIQUINOTHIAZINE; 6 PARA TOLUENOSULFONYLAMINOETHYLDIQUINOTHIAZINE; ANTINEOPLASTIC AGENT; AZAPHENOTHIAZINE DERIVATIVE; CHLORPROMAZINE; CYCLOSPORIN A; PHENOTHIAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CENTRAL NERVOUS SYSTEM TUMOR; COLON CANCER; CYTOTOXICITY; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY CANCER; LEUKEMIA; LUNG NON SMALL CELL CANCER; MELANOMA; MOUSE; NONHUMAN; OVARY CANCER; PROSTATE CANCER; TOXICITY TESTING; ANIMAL; BRAIN NEOPLASMS; COLONIC NEOPLASMS; FEMALE; MALE; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; LEUKEMIA; MALE; MELANOMA; MICE; PHENOTHIAZINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77953303960     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(10)70272-3     Document Type: Article

References (28)

1. Amaral L, Kristiansen JE: Phenothiazines: potential management of Creutzfeldt-Jacob disease and its variants. Int J Antimicrob Agents, 2001, 18, 411-417.
2. Amaral L, Martins M, Viveiros M: Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps. J Antimicrob Chemother, 2007, 59, 1237-1246.
3. Barbieri F, Alama A, Tasso B, Boido V, Bruzdo C, Sparatore F: Quinolizidinyl derivatives of iminobenzyl and phenothiazine as multidrug resistance modulators in ovarian cancer cells. Invest New Drug, 2003, 21, 413-420.
4. Gupta RR, Kumar M: Synthesis, properties and reactions of phenothiazines. In: Phenothiazines and 1,4-Benzothiazines - Chemical and Biological Aspects. Ed. Gupt, RR, Elsevier, Amsterdam, 1988, 1-161.
5. Hansen MB, Nielsen SE and Berg K: Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods, 1989, 119, 203-210.
6. Jeleń M, Pluta K: Synthesis of 6-aminoalkyldiquinithiazines and their acyl and sulfonyl derivatives. Heterocycles, 2008, 75, 859-870.
7. Mayur YC, Jagadeesh S, Thimmaiah KN: Targeting calmodulin in reversing multi drug resistance in cancer cells. Mini-Rev Med Chem, 2006, 6, 1383-1389.
8. Molnár A, Amaral L, Molnár J: Antiplasmid effect of promethazine in mixed bacterial cultures. Int J Antimicrob Agents, 2003, 22, 217-222.
9. Morak B, Nowak M, Pluta K: Determination of the lipophilicity parameters RMO and LogP of new azaphenothiazines by reversed-phase thin-layer chromatography. J Liq Chromatogr Rel Technol, 2007, 30, 1845-1854.
10. Morak B, Pluta K: RP TLC Determination of the lipophilicity of new 10-substituted 2,7-diazaphenothiazines. J Liq Chromatogr Rel Technol, 2008, 31, 611-618.
11. Morak-Młodawska B, Pluta K: Synthesis of novel dipyrido-1,4-thiazines. Heterocycles, 2007, 71, 1347-1361.
12. Mosnaim AD, Ranade VV, Wolf ME, Puente J, Valenzuela MA: Phenothiazine molecule provides the basic chemical structure for various classes of pharmacotherapeutic agents. Am J Ther, 2006, 13, 261-273.
13. Motohashi N: Antitumor activity of phenothiazines (phenothiazine Oncology). In: Phenothiazines and 1,4- Benzothiazines - Chemical and Biological Aspects. Ed. Gupta, RR, Elsevier, Amsterdam, 1988, 705-770.
14. Motohashi N, Kawase M, Saito M, Kurihara T, Hever A, Ocsocvszki I, Tanaka M, Molnár J: Synthesis and antitumor activity of 1-(2-chloroethyl)-3-(2-substituted-10H-phenothiazin-10-yl)alkyl-1-ureas as potent anticancer agents. Anticancer Res, 1996, 16, 2525-2532.
15. Motohashi N, Kawase M, Saito M, Kurihara T, Satoh K, Nakashima H, Premanathan M et al.: Synthesis and biological activity of N-acylphenothiazines. Int J Antimicrob Agents, 2000, 14, 203-207.
16. Motohashi N, Kawase M, Saito S, Sakagami H: Antitumor potential and possible targets of phenothiazinerelated compounds. Curr Drug Targets, 2000, 237-245.
17. Motohashi N, Kawase M, Satoh K, Sakagami H: Cytotoxic potential of phenothiazines. Curr Drug Targets, 2006, 7, 1055-1066.
18. Motohashi N, Kurihara T, Sakagami H, Szabo D, Csuri K, Molnár J: Chemical structure and tumor type specificity of "half-mustard type" phenothiazines. Anticancer Res, 1999, 19, 1859-1864.
19. Nagy S, Argyelan G, Molnár J, Kawase M, Motohashi N: Antitumor activity of phenothiazine-related compounds. Anticancer Res, 1996, 16, 1915-1918.
20. Nowak M, Pluta K: Study of the lipophilicity of novel diquinothiazines J Planar Chromatogr, 2006, 19, 157-160.
21. Nowak M, Pluta K, Suwińska K, Straver L: Synthesis of new pentacyclic diquinothiazines. J Heterocycl Chem, 2007, 44, 543-550.
22. Okumura H, Nakazawa J, Tsuganezawa K, Usui T, Osada H, Matsumoto T, Tanaka A, Jokohama S: Phenothiazine and carbazole-related compounds inhibit mitotic kinesin Eg5 and trigger apoptosis in transformed culture cells. Toxicol Lett, 2006, 166, 44-52.
23. PASS (Prediction of Activity Spectra for Substance) http://ibmc.msk.ru/PASS.
24. Sakagami H, Takahashi H, Yoshida H, Yamamura M, Fukuchi K, Gomi K, Motohashi N, Takeda M: Induction of DNA fragmentation in human Myelogenous Leukaemic cell lines by phenothiazine-related compounds. Anticancer Res, 1995, 15, 2533-2540.
25. Shoemaker R, H: The NCI human tumor cell line anticancer drug screen. Nature Rev, 2006, 6, 813-823.
26. Viveiros M, Martins M, Couto I, Kristiansen JE, Molnár J, Amaral L: The in vitro activity of phenothiazines against Mycobacterium avium: potential of thioridazine for therapy of the co-infected AIDS patients. In Vivo, 2005, 19, 733-736.
27. Wuonola MA, Palfreyman MG, Motohashi N, Kawase M, Gabay S, Gupta RR, Molnár J: The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm. Anticancer Res, 1998, 18, 337-348.
28. Zhelev Z, Ohba H, Bakalova R, Hadjimitova V, Ishikawa M, Shinohara Y, Baba Y: Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Cancer Chemother Pharmacol, 2004, 53, 267-275.